Results 151 to 160 of about 14,494 (232)
Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana [PDF]
, 2015 core +1 more source
Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use [PDF]
, 2015 core +1 more source
The benefits and risks of PrEP and kidney function. [PDF]
, 2016 Mocroft, A, Ryom, L
core +1 more source
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate [PDF]
, 2020 openaire +1 more source
Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate: Systematic Review and Meta-Analysis [PDF]
International Journal of Pulmonary & Respiratory Sciences, 2018 openaire +1 more source
Journal of Comparative Effectiveness ResearchAim: This study assessed the clinical impact and cost–effectiveness of switching from tenofovir disoproxil fumarate (TDF) to either tenofovir alafenamide (TAF) or entecavir (ETV) in a Greek chronic hepatitis B (CHB) population.
Emmanouil Sinakos +6 more
doaj +1 more source
Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaques. [PDF]
EBioMedicine, 2022 Makarova N +13 more
europepmc +1 more source
Distal renal tubular acidosis without renal impairment after use of tenofovir: a case report [PDF]
, 2016 Kentaro Iwata +3 more
core +1 more source
Purpose of reviewWe review macaque models for preexposure prophylaxis (PrEP) for HIV prevention and highlight their role in advancing currently approved and novel PrEP agents.Recent findingsThe development of the repeat low dose simian HIV (SHIV ...
core